Werner Meier
Direttore Tecnico/Scientifico/R&S presso Revitope Oncology, Inc.
Provenienza dei contatti di primo grado di Werner Meier
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Revitope Oncology, Inc.
Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA.
7
| Private Company | Hospital/Nursing Management | 7 |
Revitope Ltd.
Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Werner Meier tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Cardiogen Sciences, Inc.
Cardiogen Sciences, Inc. Pharmaceuticals: GenericHealth Technology Cardiogen Sciences, Inc. is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. The company was founded by Louis G. Lange in 2014 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Generic | Founder | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AUTOMOTIVE AXLES LIMITED | Auto Parts: OEM | Director/Board Member | |
University of Oxford | College/University | Undergraduate Degree | |
Imperial College London | College/University | Doctorate Degree | |
University of Cambridge | College/University | Undergraduate Degree | |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Director/Board Member | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
The Royal College of Physicians | College/University | Corporate Officer/Principal | |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal | |
EPIZYME, INC. | Biotechnology | Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree | |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Gladstone Foundation (CA) | Director/Board Member | ||
Association For Cancer Immunotherapy | Corporate Officer/Principal | ||
Amygdala Neurosciences, Inc.
Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Founder | |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Chief Tech/Sci/R&D Officer | |
GRITSTONE BIO, INC. | Biotechnology | Founder | |
Verge Analytics, Inc.
Verge Analytics, Inc. BiotechnologyHealth Technology Verge Analytics, Inc. engages in the provision of biotechnology services. It develops drugs for neurodegenerative diseases using computational genomics. The company was founded by Alice Zhang and Jason Chen in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Cell Design Labs, Inc.
Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member | |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Director/Board Member | |
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Teon Therapeutics, Inc. operates as a pharmaceutical company. It focuses on cancer immunotherapy. The company was founded by Yao Lina, Fan Peidong, Elfaith Elzein, and Liiu Jiwen in March 2018 and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member | |
IMMATICS N.V. | Biotechnology | Corporate Officer/Principal | |
DiNAQOR AG
DiNAQOR AG BiotechnologyHealth Technology DiNAQOR AG is a Swiss genetic medicine platform company that focuses on developing innovative solutions for patients with severe, inherited forms of heart disease. The private company is based in Pfäffikon, Switzerland, and has additional presence in Massachusetts and other locations. The company's lead preclinical program, DINA-001, is aimed at treating mybpc3-linked cardiomyopathy. Founded in 2019, the CEO of DiNAQOR is Johannes Holzmeister. | Biotechnology | Director/Board Member | |
EPIPHANY TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
NewAmsterdam Pharma Holding BV
NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Director/Board Member | |
BIOPLUS ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Recardia Therapeutics, Inc. | Director/Board Member | ||
ENTERPRISE 4.0 TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Adendra Therapeutics Ltd.
Adendra Therapeutics Ltd. BiotechnologyHealth Technology Adendra Therapeutics Ltd. is an emerging British biotechnology company that was founded in 2021 as a spin-out of the Francis Crick Institute. The company is based in London, UK. The company is focused on discovering and developing new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases, building on new insights into dendritic cell biology. The company was founded in 2021 by Caetano Reis E Sousa, Raj Mehta. Raj Mehta has been the CEO since 2021. | Biotechnology | Chief Executive Officer | |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Neovii Biotech GmbH
Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Biotechnology | Chief Tech/Sci/R&D Officer | |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 30 |
Regno Unito | 9 |
Germania | 7 |
Svizzera | 4 |
Paesi Bassi | 4 |
Settori
Health Technology | 30 |
Consumer Services | 7 |
Commercial Services | 5 |
Finance | 5 |
Health Services | 3 |
Posizioni
Director/Board Member | 43 |
Corporate Officer/Principal | 20 |
Independent Dir/Board Member | 14 |
Founder | 10 |
Chairman | 8 |
Contatti più connessi
Insiders | |
---|---|
Louis Lange | 35 |
Andrew Allen | 18 |
Carsten Reinhardt | 16 |
Raj Mehta | 6 |
Mark Clement | 2 |
Peter Joost | 1 |
Raj Mehta | 1 |
Andrew Roger Allen | 1 |
Stephen John Arkinstall | 1 |
Mehta Raj | 1 |
- Borsa valori
- Insiders
- Werner Meier
- Connessioni Società